Phreesia, Inc. (NYSE:PHR) Stock Position Lifted by JPMorgan Chase & Co.

JPMorgan Chase & Co. lifted its position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 144.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 145,716 shares of the company's stock after buying an additional 86,040 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.25% of Phreesia worth $3,666,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. R Squared Ltd acquired a new stake in Phreesia in the 4th quarter worth about $30,000. BankPlus Trust Department purchased a new position in shares of Phreesia during the 4th quarter worth about $34,000. Venturi Wealth Management LLC acquired a new stake in shares of Phreesia in the fourth quarter worth approximately $76,000. Smartleaf Asset Management LLC grew its holdings in Phreesia by 154.6% in the fourth quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company's stock valued at $89,000 after purchasing an additional 2,090 shares during the period. Finally, LPL Financial LLC acquired a new position in Phreesia during the fourth quarter worth approximately $216,000. Institutional investors and hedge funds own 92.10% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on PHR. Needham & Company LLC reissued a "buy" rating and set a $29.00 price objective on shares of Phreesia in a research note on Thursday, March 13th. Citigroup upped their price target on Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a research note on Friday, January 10th. Canaccord Genuity Group lifted their price objective on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, March 13th. Piper Sandler reissued an "overweight" rating and set a $33.00 target price (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Finally, Royal Bank of Canada upgraded shares of Phreesia from a "sector perform" rating to an "outperform" rating and raised their price target for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Phreesia presently has an average rating of "Buy" and an average price target of $31.33.

Phreesia Stock Down 0.6 %

PHR traded down $0.16 during trading hours on Friday, reaching $24.43. 42,376 shares of the stock traded hands, compared to its average volume of 432,334. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The company has a market cap of $1.44 billion, a price-to-earnings ratio of -16.62 and a beta of 0.82. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The firm's fifty day simple moving average is $25.62 and its two-hundred day simple moving average is $24.34.

Insider Buying and Selling at Phreesia

In other Phreesia news, insider Yvonne Hui sold 1,878 shares of the company's stock in a transaction that occurred on Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total value of $44,790.30. Following the transaction, the insider now directly owns 28,449 shares of the company's stock, valued at $678,508.65. This represents a 6.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP David Linetsky sold 11,685 shares of the firm's stock in a transaction that occurred on Monday, January 27th. The stock was sold at an average price of $27.48, for a total transaction of $321,103.80. Following the sale, the senior vice president now directly owns 231,271 shares of the company's stock, valued at $6,355,327.08. The trade was a 4.81 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 146,930 shares of company stock valued at $4,067,102 in the last ninety days. Insiders own 5.80% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.